1. Home
  2. AROW vs VOR Comparison

AROW vs VOR Comparison

Compare AROW & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$36.41

Market Cap

529.9M

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$16.05

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
VOR
Founded
1851
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
755.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AROW
VOR
Price
$36.41
$16.05
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$28.00
$45.33
AVG Volume (30 Days)
87.5K
1.2M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
3.30%
N/A
EPS Growth
49.72
N/A
EPS
2.65
N/A
Revenue
N/A
N/A
Revenue This Year
$33.36
N/A
Revenue Next Year
$18.26
N/A
P/E Ratio
$13.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.34
$0.13
52 Week High
$36.55
$49.95

Technical Indicators

Market Signals
Indicator
AROW
VOR
Relative Strength Index (RSI) 75.06 55.16
Support Level $31.14 $11.38
Resistance Level $36.44 $16.88
Average True Range (ATR) 0.74 1.63
MACD 0.35 0.05
Stochastic Oscillator 95.91 50.81

Price Performance

Historical Comparison
AROW
VOR

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: